Preclinical News and Research

RSS
American Cancer Society awards 85 institutions with $49,213,000 for new research, training

American Cancer Society awards 85 institutions with $49,213,000 for new research, training

Researchers develop new cancer treatment

Researchers develop new cancer treatment

Lilly presents results of JAK2, Hedgehog inhibitor preclinical cancer studies at 102nd AACR

Lilly presents results of JAK2, Hedgehog inhibitor preclinical cancer studies at 102nd AACR

VisualSonics demonstrates Vevo LAZR imaging system at AACR conference

VisualSonics demonstrates Vevo LAZR imaging system at AACR conference

Inserm Transfert, MedImmune collaborate to advance medical science research

Inserm Transfert, MedImmune collaborate to advance medical science research

Cardioxyl's CXL-1020 preclinical data against heart failure presented at ACC meeting

Cardioxyl's CXL-1020 preclinical data against heart failure presented at ACC meeting

Caliper introduces novel fluorescent imaging agent for pre-clinical research

Caliper introduces novel fluorescent imaging agent for pre-clinical research

Morphotek acquires tumor targeting assets from TMI

Morphotek acquires tumor targeting assets from TMI

Sofie Biosciences launches GENISYS4 benchtop small animal PET system

Sofie Biosciences launches GENISYS4 benchtop small animal PET system

ImmunoGen presents IMGN529 data against NHL, CLL at AACR meeting

ImmunoGen presents IMGN529 data against NHL, CLL at AACR meeting

Oncothyreon's ONT-10, PX-866 preclinical data presented at AACR meeting

Oncothyreon's ONT-10, PX-866 preclinical data presented at AACR meeting

ImmunoGen presents IMGN853 data against ovarian cancer, carcinomas at AACR meeting

ImmunoGen presents IMGN853 data against ovarian cancer, carcinomas at AACR meeting

Stealth announces Bendavia Phase I clinical study results against ischemia reperfusion injury

Stealth announces Bendavia Phase I clinical study results against ischemia reperfusion injury

Human immune system can help predict recurrence, overall breast cancer survival

Human immune system can help predict recurrence, overall breast cancer survival

New research reveals potential treatment for HO in children, soldiers

New research reveals potential treatment for HO in children, soldiers

Entry inhibitors can provide first new hepatitis B & D treatments for many years

Entry inhibitors can provide first new hepatitis B & D treatments for many years

Experts must monitor new antiviral compounds for HCV treatment

Experts must monitor new antiviral compounds for HCV treatment

Pfizer to present new investigational compounds data against cancer at AACR meeting

Pfizer to present new investigational compounds data against cancer at AACR meeting

Three abstracts from SuperGen PIM kinase inhibitor program to be presented at AACR

Three abstracts from SuperGen PIM kinase inhibitor program to be presented at AACR

PBI commits to sponsor APS Novel Disease Model Awards for 2011 through 2013

PBI commits to sponsor APS Novel Disease Model Awards for 2011 through 2013

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.